Not Yet RecruitingPhase 3ACTRN12610000840088

Single Patient Multiple Cross-Over Trials To Determine The Efficacy Of Pilocarpine In Relieving Dry Mouth In Patients With Cancer


Sponsor

University of Queensland

Enrollment

70 participants

Start Date

Nov 1, 2010

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 100 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether pilocarpine eye drops taken by mouth can relieve chronic dry mouth in cancer patients. It is for adults aged 18 and older with advanced cancer who have had persistent dry mouth for at least 2 weeks with no expected improvement.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Active pilocarpine 4% (40 mg/ml) drops; Pilcoarpine (po) 2-3 drops 3 times daily (4-6 mg three times daily) with meals in raspberry water delivered as a mouth dropper. Rasberry water is combined w

Active pilocarpine 4% (40 mg/ml) drops; Pilcoarpine (po) 2-3 drops 3 times daily (4-6 mg three times daily) with meals in raspberry water delivered as a mouth dropper. Rasberry water is combined with the active treatment in order to simulate the taste of the placebo, rasberry water. This is to ensure the patient remains blind to the treatment. The active treatment will be administered in a cycle pair. A cycle pair is a course of treatment over 6 days. For 3 consecutive days, the patient will take the active treatment followed by 3 days on placebo. The duration of the trial will consist of 3 cycle pairs taking place over 18 days. A follow-up on day 19 by the patients physician will then take place. A washout period will be instigated on the first day of each cycle. On that day, no measurements will be taken.


Locations(1)

NSW,QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000840088